Using AI to help find answers for Cancer diagnosis 

To conduct scientific research and further our dedication to providing best-in-class technical expertise that improve benefit-risk profile of treatments for patients diagnosed with cancer. Using real-world publicly available clinical trial datasets. Olu developed principal component algorithms to measure and accelerate treatment response insights for patients living with cancer. The aim is to help identify the most effective treatments for patients to drive and guide treatment decision-making in clinical practice for an estimated 2.1 people of all ages diagnosed with cancer in 2021.